Rosuvastatin (Crestor) and rhabdomyolysis

CMAJ. 2004 Jul 20;171(2):129. doi: 10.1503/cmaj.1041051.
No abstract available

MeSH terms

  • Canada
  • Dose-Response Relationship, Drug
  • Fluorobenzenes / administration & dosage
  • Fluorobenzenes / adverse effects*
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / administration & dosage
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects*
  • Hyperlipidemias / drug therapy*
  • Pyrimidines / administration & dosage
  • Pyrimidines / adverse effects*
  • Rhabdomyolysis / chemically induced*
  • Rhabdomyolysis / physiopathology
  • Rosuvastatin Calcium
  • Sulfonamides / administration & dosage
  • Sulfonamides / adverse effects*

Substances

  • Fluorobenzenes
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Pyrimidines
  • Sulfonamides
  • Rosuvastatin Calcium